동향
동향 내용
Quantification of β-amyloidosis and rCBF with dedicated PET, 7 T-MR imaging and high-resolution microscopic MR imaging at 16.4 T in APP23 mice.
분류 PET 조회 2246
발행년도 2015 등록일 2015-10-17
출처 J Nucl Med (바로가기)
Non-invasive quantification of the amyloid-load is of paramount interest in the field of Alzheimerŕs disease research. We present a combined PET/7 T-MRI and 16.4 T-microscopic-MRI (µMRI) dual-modality imaging approach enabling the quantification of the amyloid-load at high-sensitivity and high-resolution, and of regional cerebral blood flow (rCBF) in the brain of transgenic APP23 mice. Moreover, we demonstrate a novel, voxel-based correlative data analysis method which we used for in-depth evaluation of amyloid-PET and rCBF-data.
 
METHODS:
 
We injected [11C]PIB intravenously in transgenic (tg) and control (co) APP23 mice and performed dynamic PET measurements. rCBF-data were recorded with a flow sensitive alternating inversion recovery (FAIR) approach at 7 T. Subsequently, animals were sacrificed and brains harvested for ex vivo µMRI at 16.4 T with a T2*-weighted gradient-echo sequence at 30 µm spatial resolution. Additionally, correlative amyloid histology was performed. The [11C]PIB-PET data were quantified to non-displaceable binding potentials (BPnd) using the Logan graphical analysis; FAIR-data were quantified with a simplified version of the Bloch equation.
 
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Diffusion-weighted and PET/MR Imaging after Radiation Therapy for Malignant Head and Neck Tumors.
다음글다음글 Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer.